The Efficacy and Safety of Huaiqihuang Granule in Children With Chronic Primary Immune Thrombocytopenia
Status:
Recruiting
Trial end date:
2022-09-20
Target enrollment:
Participant gender:
Summary
This is a multisite, double-blind, randomized, placebo-controlled, and parallel study
designed to evaluate the clinical efficacy and safety of Huaiqihuang granule for treatment to
children with chronic primary immune thrombocytopenia (Qi Yin deficiency).